v3.26.1
Schedule of Fair Value Assets Measured on Recurring Basis (Details) - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
PIPE Warrants [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Beginning balance $ 79,512 $ 273,124
Fair value adjustment (79,232) (193,612)
Exchanged for Common Stock  
Exchanged for Series B Convertible Preferred Stock and Series B Warrants  
Ending balance 280 79,512
Abaca Warrant [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Beginning balance 1,024,900 3,384,085
Fair value adjustment (996,470) (2,359,185)
Exchanged for Common Stock  
Exchanged for Series B Convertible Preferred Stock and Series B Warrants  
Ending balance 28,430 1,024,900
Private Placement Warrants [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Beginning balance 9,632 25,070
Fair value adjustment (9,618) (15,438)
Exchanged for Common Stock  
Exchanged for Series B Convertible Preferred Stock and Series B Warrants  
Ending balance 14 9,632
Third Anniversary Payment Consideration [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Beginning balance 322,000 810,000
Fair value adjustment (63,133) (488,000)
Exchanged for Common Stock 258,867  
Exchanged for Series B Convertible Preferred Stock and Series B Warrants  
Ending balance 322,000
Forward Purchase Derivative [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Beginning balance 7,309,580 7,309,580
Fair value adjustment
Exchanged for Common Stock  
Exchanged for Series B Convertible Preferred Stock and Series B Warrants (7,309,580)  
Ending balance $ 7,309,580